Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Chandrikha Chandrasekharan, MBBS
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Optimizing Treatment Intensity in Early-Stage TNBC
Roberto Leon-Ferre, MD
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Jennifer Johnson, MD, PhD
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Stephanie Gregory, CNP
Managing High-Risk Subgroups in Metastatic NSCLC
Melina Marmarelis, MD
Deepa Rangachari, MD
Managing Immune-Related Adverse Events in Metastatic NSCLC
Paul Bunn, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP
Doris M. Ponce, MD, MS
Emerging Therapeutic Strategies in Metastatic NSCLC
Urs Weber, MD
Shared Decision-Making in Colorectal Cancer Screening
Gates B. Colbert, MD
Sarina Schrager, MD
Lashika Yogendran, MD
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Laura Alder, MD
Christine Bestvina, MD
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Adam Brufsky, MD, PhD
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Daniel Geynisman, MD
Jonathan Henderson, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.